The early days of July 2015 brought two pieces of good news for Theranos. The first was that the FDA had approved the company's proprietary finger-stick test for HSV-1, one of two strains of herpes virus. The second was that a new law Arizona had passed allowing its citizens to get their blood tested without a doctor's order -- a bill Theranos had practically written itself and heavily lobbied for -- was about to go into effect.

…

…

…

 

>> 网页版功能未完善，完整内容，请使用微信小程序。